| 摘要 |
<p>Drugs for ameliorating retinal function which contain as the active ingredient sproteins having an effect of ameliorating electroretinogram (ERG). In particular, preparations containing as the active ingredient tissue-factor-pathway inhibitor-2 or placental protein 5 are usable as drugs for ameliorating retinal function in the treatment of ophthalmic diseases such as glaucoma, retinal vaso-occlusion and retinal malfunction.</p> |
